Lifeloc Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 09, 2022 at 06:28 pm EDT
Share
Lifeloc Technologies, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.022639 million compared to USD 0.021939 million a year ago. Revenue was USD 2.18 million compared to USD 1.73 million a year ago. Net loss was USD 0.20153 million compared to USD 0.109712 million a year ago. Basic loss per share from continuing operations was USD 0.08 compared to USD 0.04 a year ago. Diluted loss per share from continuing operations was USD 0.08 compared to USD 0.04 a year ago.
For the six months, sales was USD 0.044878 million compared to USD 0.043471 million a year ago. Revenue was USD 4.34 million compared to USD 3.54 million a year ago. Net loss was USD 0.346038 million compared to net income of USD 0.293759 million a year ago. Basic loss per share from continuing operations was USD 0.14 compared to basic earnings per share from continuing operations of USD 0.12 a year ago. Diluted loss per share from continuing operations was USD 0.14 compared to diluted earnings per share from continuing operations of USD 0.12 a year ago.
Lifeloc Technologies, Inc. is a manufacturer of evidential breath alcohol testers and related training and supplies for workplace, law enforcement, corrections, and international customers. The Company designs, produces and sells fuel-cell based breath alcohol testing equipment. It operates through two segments: Products and Rentals. The Products segment is engaged in the sale of physical products, including portable hand-held breathalyzers and related accessories, supplies, education, training, and royalties from development contracts with original equipment manufacturers (OEMs). The Rentals segment is engaged in the rental of a portion of its building. In addition, the Company offers a line of supplies, accessories, services, and training to support customers alcohol testing programs. It sells globally through distributors as well as directly to users. It sells certain of its components to customers for incorporation into their own product lines and for resale under their own name.